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[https://doi.org/10.1016/j.nicl.2019.102054](10.1016/j.nicl.2019.102054){#intref0015}**Value of the Data**•Volumetric brainstem data in ALS and PLS reveal medulla oblongata and pons atrophy compared to healthy and disease controls•The dataset provides evidence of phenotype-specific brainstem profiles in motor neuron diseases and is consistent with post mortem studies, pathological TDP-43 staging systems, and the clinical profile of the phenotypes.•The presented data demonstrate that ALS-specific imaging signatures can be captured in the brainstem based on T1-weighted datasets alone.•This dataset may be useful for biomarker development for pharmaceutical trials in motor neuron diseases.

1. Data {#sec1}
=======

Despite pathognomonic bulbar involvement in motor neuron diseases \[[@bib2], [@bib3], [@bib4]\], the majority of imaging studies in ALS and PLS focus on cortical and spinal cord signatures \[[@bib5], [@bib6], [@bib7], [@bib8], [@bib9]\]. In this dataset we present the volumetric brainstem profile of 100 patients with amyotrophic lateral sclerosis (ALS), 33 patients with primary lateral sclerosis (PLS), 30 patients with frontotemporal dementia (FTD), and 100 age-matched healthy controls (HC) \[[@bib1]\] ([Table 1](#tbl1){ref-type="table"}). Relevant demographic (age, gender, education and handedness) and clinical (ALSFRS-r) characteristics \[[@bib10],[@bib11]\] are presented in the companion article \[[@bib1]\]. Raw volumetric data for each brainstem segment are available online at Mendeley Data; <https://doi.org/10.17632/4t8c4bmw5p.3> Longitudinal brainstem changes in ALS \[[@bib12]\] are presented in boxplots ([Fig. 1](#fig1){ref-type="fig"}). Reference volumetric data are shown for PLS patients \[[@bib13]\], disease controls \[[@bib14],[@bib15]\] and healthy controls \[[@bib16]\] to aid the interpretation of ALS-associated brainstem changes. Based on estimated marginal means corrected for age, gender, total intracranial volumes and education, the comparative profile of the study groups are further illustrated in radar plots with reference to healthy controls ([Fig. 2](#fig2){ref-type="fig"}). Focal atrophy patterns are presented as three-dimensional vertex projections ([Fig. 3](#fig3){ref-type="fig"}).Table 1Data categories and measures.Table 1Data categoriesSpecific measuresSegmental brainstem volumesMedulla oblongata volume (mm^3^)Pons volume (mm^3^)Mesencephalon volume (mm^3^)Vertex contrast between ALS patients and healthy controlsVertex locations of individual participants are projected on the surface of an average brainstem template as scalar values. Permutation based non-parametric statistics were used for group comparisons including age, gender and education. Resulting statistical maps are displayed on 3D mesh templates to showcase focal shape deformations.[^1]Fig. 1The comparative volumetric brainstem profile of patients with amyotrophic lateral sclerosis at time-point 1 (ALST1), patients with amyotrophic lateral sclerosis at time-point 2 (ALST2), frontotemporal dementia (FTD), healthy controls (HC) and patients with primary lateral sclerosis (PLS).Fig. 1Fig. 2The segmental brainstem profile of ALS, PLS and FTD with reference to healthy controls. 100% represents the estimated marginal mean of healthy controls for each structure. Estimated marginal means of volumes were calculated with the following values Age = 59.59, Gender = 1.43, Education = 13.63, TIV = 1435355.28.Fig. 2Fig. 3Anatomical patterns of atrophy in ALS compared to healthy controls based on vertex-analyses after corrections for demographic variables. **Top**: Vertex analyses; brainstem mesh is shown in blue and shape deformations are highlighted in orange at p \< 0.05 FWE **Bottom**: Surface-based vertex analyses; the brainstem mesh template is shown in red.Fig. 3

2. Experimental design, materials, and methods {#sec2}
==============================================

This protocol was approved by the institutional ethics committee and each participant provided informed consent. Recruitment, anonymisation and data management procedures followed institutional and EU data handling guidelines (GDPR). Patients were recruited from a national motor neuron disease clinic to participate in a standardised imaging protocol \[[@bib8]\]. Participating ALS patients were diagnosed according to the El Escorial research criteria, PLS patients were diagnosed according to the Gordon criteria and FTD patients according to the Rascovsky criteria \[[@bib17]\]. The study was designed to characterise brainstem degeneration in ALS and PLS with a view to identify distinguishing imaging characteristics for diagnostic classification applications \[[@bib18],[@bib19]\]. T1-weighted images were acquired with a spatial resolution of 1 × 1 × 1mm and field of view of 256 × 256 × 160 mm using a 3D Inversion Recovery prepared Spoiled Gradient Recalled echo (IR-SPGR) sequence; repetition time (TR) = 8.5 ms, echo time (TE) = 3.9 ms, Inversion time (TI) = 1060 ms, flip angle = 8°, SENSE factor = 1.5. Whole brainstem volumes and total intracranial volumes (TIV) were estimated using FSL-FIRST \[[@bib20]\] of the FMRIB\'s Software Library (FSL) \[[@bib7],[@bib14]\].

The brainstem of each participant was further segmented into the medulla oblongata, pons, and mesencephalon using a Bayesian parcellation algorithm implemented in version 6.0 of the FreeSurfer image analysis suite. Analyses of covariance (ANCOVA) were used to explore intergroup volumetric differences using age, education, gender and TIV as covariates \[[@bib11]\]. To illustrate disease-specific volumetric traits in ALS and PLS, the estimated marginal mean of each segment was plotted on a radar chart with reference to healthy controls.

As volumetric profiling only detects global volume reductions, additional vertex analyses were performed to characterise focal shape deformations in ALS compared to healthy controls. FMRIB\'s subcortical segmentation and registration tool FIRST was used for shape analyses to map surface-projected atrophy patterns in the brainstem. ALS patients at their second time point exhibited considerable bilateral flattening of the medullary pyramids above the pyramidal decussation ([Fig. 3](#fig3){ref-type="fig"}).
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[^1]: ALS = amyotrophic lateral sclerosis; ALSFRS-R = amyotrophic lateral sclerosis functional rating scale-revised; PLS = Primary lateral sclerosis.
